Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clarivate (CLVT) Cash & Equivalents (2017 - 2025)

Clarivate's Cash & Equivalents history spans 9 years, with the latest figure at $329.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 11.52% year-over-year to $329.2 million; the TTM value through Dec 2025 reached $329.2 million, up 11.52%, while the annual FY2025 figure was $329.2 million, 11.52% up from the prior year.
  • Cash & Equivalents reached $329.2 million in Q4 2025 per CLVT's latest filing, up from $318.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.6 billion in Q2 2021 to a low of $295.2 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $594.4 million, with a median of $373.6 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: surged 320.63% in 2021, then plummeted 85.95% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $430.9 million in 2021, then decreased by 17.2% to $356.8 million in 2022, then rose by 3.9% to $370.7 million in 2023, then decreased by 20.37% to $295.2 million in 2024, then rose by 11.52% to $329.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLVT's Cash & Equivalents are $329.2 million (Q4 2025), $318.7 million (Q3 2025), and $362.6 million (Q2 2025).